Alejandro Aranda

发表

Capsid-deficient alphaviruses generate propagative infectious microvesicles at the plasma membrane

J. Prieto, N. Abrescia, C. Smerdou, 2016, Cellular and Molecular Life Sciences.

Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma

C. Smerdou, Noelia Silva-Pilipich, E. Martišová, 2021, Scientific Reports.

Influence of silver electrochemically deposited onto zinc oxide seed nanoparticles on the photoelectrochemical performance of zinc oxide nanorod films

R. Landers, H. Alarcon, R. Candal, 2019, Nanomaterials and Nanotechnology.

Alphavirus vectors for cancer therapy.

C. Smerdou, J. Bezunartea, Marta Ruiz-Guillen, 2010, Virus research.

A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system

J. Prieto, E. Larrea, C. Smerdou, 2014, Cellular and Molecular Life Sciences.

A simple and efficient method for the production of human glycosylated glial cell line-derived neurotrophic factor using a Semliki Forest virus expression system.

E. Ansorena, E. Garbayo, M. Blanco-Prieto, 2013, International journal of pharmaceutics.

Recent patents on alphavirus protein expression and vector production.

C. Smerdou, J. Bezunartea, Marta Ruiz-Guillen, 2011, Recent patents on biotechnology.

A novel system for the production of high levels of functional human therapeutic proteins in stable cells with a Semliki Forest virus noncytopathic vector.

J. Prieto, C. Smerdou, Marta Ruiz-Guillen, 2010, New biotechnology.

[Herpes simplex virus type 1 latency and reactivation: an update].

A. Epstein, Alejandro Aranda, A. Aranda, 2015, Medecine sciences : M/S.